What is Vertex Pharmaceuticals's united states — total long-lived assets?

Vertex Pharmaceuticals (VRTX) reported united states — total long-lived assets of $2.89B in Q4 2025.

United States — Total long-lived assets

Vertex Pharmaceuticals United States — Total long-lived assets increased by 20.7% to $2.89B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $2.39B to $2.89B.

Analysis

StatementSegment

First reportedQ4 2017

Last reportedQ4 2025Feb 13, 2026

Rolls up toPP&E (Net)

Metric ID: vrtx_segment_united_states_total_long_lived_assets

Historical Data

5 periods

	Q4 '21	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$1.35B	$1.37B	$1.36B	$2.39B	$2.89B
QoQ Change	—	+1.3%	-0.4%	+76.0%	+20.7%
YoY Change	—	+1.3%	-0.4%	+76.0%	+20.7%

Range$1.35B – $2.89B

CAGR+114.3%

Avg YoY Growth+24.4%

Median YoY Growth+11.0%

Current Streak2 quarters growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's united states — total long-lived assets?: Vertex Pharmaceuticals (VRTX) reported united states — total long-lived assets of $2.89B in Q4 2025.
How has Vertex Pharmaceuticals's united states — total long-lived assets changed year-over-year?: Vertex Pharmaceuticals's united states — total long-lived assets increased by 20.7% year-over-year, from $2.39B to $2.89B.